PRO-DEX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
PRO-DEX, INC. (PDEX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 6.50 thousand shares as of 2022-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2023-05-04
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 6.50K shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 6.50K shares.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 31.50K shares.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 31.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2022-03-31 | 6.50K shares 10-Q · filed 2023-05-04 |
| 2021-12-31 | 6.50K shares 10-Q · filed 2023-02-02 |
| 2021-06-30 | 31.50K shares 10-K · filed 2021-09-09 |
| 2021-03-31 | 31.50K shares 10-Q · filed 2022-05-05 |
| 2020-12-31 | 31.50K shares 10-Q · filed 2022-02-03 |
| 2020-06-30 | 54.00K shares 10-K · filed 2021-09-09 |
| 2020-03-31 | 54.00K shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 54.00K shares 10-Q · filed 2020-02-06 |
| 2019-06-30 | 54.00K shares 10-K · filed 2020-09-10 |
| 2019-03-31 | 54.00K shares 10-Q · filed 2020-05-07 |
| 2018-12-31 | 54.00K shares 10-Q · filed 2020-02-06 |
| 2018-06-30 | 57.00K shares 10-K · filed 2019-09-12 |
| 2018-03-31 | 57.00K shares 10-Q · filed 2019-05-09 |
| 2017-12-31 | 57.00K shares 10-Q · filed 2019-02-07 |
| 2017-09-30 | 57.00K shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 57.00K shares 10-K · filed 2017-09-14 |
| 2017-03-31 | 62.83K shares 10-Q · filed 2018-05-10 |
| 2016-12-31 | 62.83K shares 10-Q · filed 2018-02-08 |
| 2016-09-30 | 65.83K shares 10-Q · filed 2017-11-09 |
| 2016-06-30 | 90.83K shares 10-K · filed 2016-09-15 |
| 2016-03-31 | 90.83K shares 10-Q · filed 2017-05-11 |
| 2015-12-31 | 99.17K shares 10-Q · filed 2017-02-09 |
| 2015-09-30 | 106.67K shares 10-Q · filed 2016-11-10 |
| 2015-06-30 | 101.67K shares 10-K · filed 2015-09-17 |
| 2015-03-31 | 101.67K shares 10-Q · filed 2016-05-12 |
| 2014-12-31 | 150.00K shares 10-Q · filed 2016-02-11 |
| 2014-09-30 | 150.00K shares 10-Q · filed 2015-11-10 |
| 2014-06-30 | 145.84K shares 10-K · filed 2014-09-18 |
| 2014-03-31 | 142.50K shares 10-Q · filed 2015-05-14 |
| 2013-12-31 | 148.06K shares 10-Q · filed 2015-02-10 |
| 2013-09-30 | 139.73K shares 10-Q · filed 2014-11-13 |
| 2013-06-30 | 197.92K shares 10-K · filed 2013-09-27 |
| 2013-03-31 | 274.73K shares 10-Q · filed 2014-05-12 |
| 2012-12-31 | 250.98K shares 10-Q · filed 2014-02-06 |
| 2012-09-30 | 268.89K shares 10-Q · filed 2013-11-13 |
| 2012-06-30 | 276.95K shares 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |